VialVIAL
HomeDirectoryCompounding PharmacyBoothwyn Pharmacy LLC

Federal record

FDA Warning Letter issued January 16, 2026 · As of November 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →

We're providing this information based on regulatory filings Vial reviewed as of 2026-11-11. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →

Boothwyn Pharmacy LLC
Compounding Pharmacy

Boothwyn Pharmacy LLC

Reviewed by Vial Editorial · November 1, 2026

Kennett Square, PA

Is this your company? Claim this profile.

Boothwyn Pharmacy is a compounding pharmacy. The FDA issued a warning letter involving Boothwyn Pharmacy on January 16, 2026, with no close-out letter found resolving it. Pricing was not publicly listed, so total cost should be confirmed before signing up.

What they offerCompounding Pharmacy

38/100
Flagged
Why this score?

The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.

85-100High Confidence
70-84Well Documented
50-69Limited Confidence
0-49Flagged

Boothwyn Pharmacy LLC scores 38, in the Flagged band. The score moves when the public record changes. For Boothwyn Pharmacy LLC, the item most likely to move it: Pricing.

Payment never changes a score.

5 of 7 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.

Score history

38 since May 2026. Last checked November 1, 2026.

What we found on Boothwyn Pharmacy LLC

We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, NPI registration, PCAB accreditation, and FDA 503B registration.

The FDA issued a warning letter involving Boothwyn Pharmacy LLC on January 16, 2026. We have not found a close-out letter resolving it as of our last check (November 11, 2026); read the details below before going further. The company appears in the federal NPI registry. Our findings reflect public records reviewed as of November 2026.

Why this score: 5 of 7 checks complete. Each links to the public source it was verified against.

Federal actions
Confirmed. See the full report for detail.
See the full report for the details of this record.
FDA.govOIG LEIEDEA DiversionHHS OCR Portal
Checked November 11, 2026
Pricing
Not publicly listed
Not publicly listed. Confirm total monthly cost before enrolling.
Physicians named
Not publicly identified
NPI registration
Registered in the CMS NPI registry as of 2026-11-02.
confirms a recognized healthcare entity in the federal registry.
CMS NPI Registry
Checked November 2, 2026
PCAB accreditation
No PCAB accreditation on file as of 2026-06-04.
PCAB is the primary accreditation standard for compounding pharmacies.
ACHC / PCAB
Checked June 4, 2026
FDA 503B registration
Not on the FDA 503B outsourcing registry as of 2026-11-02 (most compounders operate under 503A).
503B registration applies to outsourcing facilities; most compounders operate under 503A.
FDA 503B Registry
Checked November 2, 2026
LegitScript certification
Not checked yet
not found is not failed. It means unconfirmed.
Show all evidence (7) Show fewer

A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.

Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed November 1, 2026.

Our take

Vial Editorial

Based on the records and public materials we reviewed.

Boothwyn Pharmacy is a compounding pharmacy in Kennett Square, Pennsylvania. They make sterile and non-sterile compounded medications for people and animals, including GLP-1 injections, and say they are owned and operated by pharmacists. They fill prescriptions from physicians and veterinarians who work directly with their pharmacists; there is no patient-facing store or price list. They say 90% of orders ship within 48 hours of receipt. We found no refund, cancellation or insurance policy on their sites.

No pharmacist in charge or clinician is named on their site. The FDA issued a warning letter to Boothwyn Pharmacy, LLC on January 16, 2026. We found no close-out letter for it in FDA records checked on {check date}. The letter is published at {FDA link}. The FDA issued a warning letter to Boothwyn Pharmacy LLC on June 9, 2025. We found no close-out letter for it in FDA records checked on October 27, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/boothwyn-pharmacy-llc-710247-06092025. A third letter, dated July 25, 2018, is covered in our compliance notes. On Trustpilot they average 2.4 from 10 reviews, with 70% at one star.

5 of 7 key checks found
2 important details still need to be confirmed directly.

What it costs

They publish no prices and no patient-facing ordering page. A prescriber sends the prescription and works with their pharmacists on the formulation, and the cost a patient pays comes from that clinic or from the pharmacy when it dispenses. Their sites do not say whether they bill insurance or accept HSA or FSA, and we found no refund or cancellation policy. Shipping is described as 2-day for most orders, with 90% shipping within 48 hours, and they note delays for weather, carrier issues and remote or P.O. Box addresses. Before paying, get the price per prescription, the shipping charge, the cold-chain handling for injectables, and their replacement terms for a late or damaged shipment in writing.

Sources: boothwyn.com · boothwynquality.com · boothwynquality.com · businesswire.com · fda.gov · fda.gov · fda.gov · pa.gov · pharmacy.ca.gov · health.maryland.gov · getvial.com

What patients report

On Trustpilot they average 2.4 from 10 reviews as of October 27, 2026, with 70% at one star, 20% at two stars and 10% at five stars; the newest review is dated December 17, 2025 and the profile is unclaimed. Negative reviews mostly describe shipments that took weeks or had not shipped two weeks after the charge and orders that arrived short, and some describe temperature or color concerns with the product and replies they call canned. The single five-star review praises fast delivery. Our search found no BBB profile. The pattern is a small, mostly negative review base centered on fulfillment.

Sources: trustpilot.com

What the record means

Vial scores Boothwyn Pharmacy 38 out of 100, Flagged.

The FDA issued a warning letter to Boothwyn Pharmacy, LLC on January 16, 2026. We found no close-out letter for it in FDA records checked on {check date}. The letter is published at {FDA link}. The FDA issued a warning letter to Boothwyn Pharmacy LLC on June 9, 2025. We found no close-out letter for it in FDA records checked on October 27, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/boothwyn-pharmacy-llc-710247-06092025. The FDA issued a warning letter to Boothwyn Pharmacy LLC on July 25, 2018. We found no close-out letter for it in FDA records checked on October 27, 2026. The letter is published at https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm619573.htm. The Pennsylvania Department of State announced on October 21, 2025 that Boothwyn admitted violating the Pharmacy Act under a consent agreement, with a $1 million civil penalty and probation on their license. The California State Board of Pharmacy issued a cease and desist order on June 23, 2025 and lifted it on July 10, 2025. The Maryland Board of Pharmacy reprimanded their Maryland permit and fined them $8,750 by consent order in 2026. They say they hold PCAB accreditation through ACHC and NABP accreditation as of February 2026, which we have not checked. We haven't checked LegitScript yet. They publish no state list. The legal name on the FDA letters is Boothwyn Pharmacy LLC. Each letter and order is linked in our sources.

Worth asking before you choose

Ask these before you sign up.

Screenshot these or show your doctor: they’re the same questions Vial would ask.

Compare record details

Near-identical on the public record; the choice comes down to fit: treatment type, state availability, and pricing.

Boothwyn Pharmacy LLCProRX LLC
Federal actionsConfirmedConfirmed
Vial Score38/10038/100
LegitScript certifiedNoNo
PCAB accreditedNoNo

What Vial measures, and what we don’t

We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.

Other compounding pharmacy providers in Vial

Other Compounding Pharmacy in Vial’s directory. Open a profile, or compare side by side.

ProRX LLCProRX LLC5 of 7 checks complete
AnazaoHealthAnazaoHealth5 of 7 checks complete
Annovex Pharma, Inc.Annovex Pharma, Inc.5 of 7 checks complete
Apothecary Pharma LLCApothecary Pharma LLC5 of 7 checks complete
See 2 more alternativesShow fewer

Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.

Find your provider
Are you Boothwyn Pharmacy LLC?
Dispute findings by providing documentation
Dispute
Sources reviewed as of November 2026

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.